Exocrine Pancreatic Insufficiency Therapeutics and Diagnostics Market Estimated to Cross US $6,414.4 Mn by 2025
The presence of a handful of companies in the global Exocrine Pancreatic Insufficiency Therapeutics and Diagnostics Market has rendered the vendor landscape largely consolidated and mildly competitive, observes Transparency Market Research in a new report. Companies contributing to the global EPI therapeutics and diagnostics market are mostly concentrated in Europe and North America.
View full press release